Prohibits persons from interfering with another person's access to or from a health care facility or disrupting the normal functioning of a health care facility. Makes violations a petty misdemeanor. Establishes a private right of action. Authorizes the Attorney General to bring an action for injunctive or other equitable relief. (SD1)
By 1/1/2027, requires all state and county agencies that operate protected community locations to adopt and post written policies that identify nonpublic areas, establish procedures for warrant verification and staff response, prohibit the collection of certain immigration-status data, and require annual staff training and certain multilingual notices. Requires the Attorney General to publish model policies. (CD1)
Expands the protections established under Act 2, SLH 2023, to include gender-affirming health care services, including clarifying permitted disclosures of protected health information to address changes in federal regulations. Establishes protections against abusive litigation. Prohibits medical malpractice insurers and health carriers from taking certain adverse actions against health care providers solely on the basis that the health care provider provides lawful reproductive health care services or gender-affirming health care services. (SD2)
This Senate Resolution urges Hawaii's Department of Health to coordinate storing a three-year supply of mifepristone, a medication used in medical abortions. The bill directly affects the state's public health infrastructure and aims to ensure continued access to abortion care by maintaining a medication supply that could be affected by FDA policy changes or supply chain disruptions. It builds on the state's existing reproductive health protections and acknowledges that mifepristone has a five-year shelf life, making long-term stockpiling feasible. The resolution is non-binding and directs the Department of Health to determine the appropriate quantities needed for this three-year supply.
This Senate Concurrent Resolution (SCR 7) affirms Hawaii's support for hospitals providing emergency medical care - including abortion services - when medically necessary to stabilize pregnant patients under federal law (EMTALA). It directly addresses hospitals in Hawaii, urging all facilities (including religiously affiliated ones) to uphold EMTALA’s requirement to deliver life-saving care for conditions like hemorrhage or ectopic pregnancy. The resolution responds to recent federal policy shifts causing confusion about EMTALA’s application, reinforcing that hospitals must not delay or deny such care. It does not create new legal requirements but formally aligns Hawaii’s healthcare system with existing federal standards.
Senate Resolution 7 affirms Hawaii's support for the federal Emergency Medical Treatment and Active Labor Act (EMTALA), which requires hospitals to provide life-saving emergency care - including abortion services when medically necessary - to stabilize pregnant patients experiencing medical emergencies. The resolution urges all Hawaii hospitals, regardless of religious affiliation, to uphold EMTALA's requirements and ensure no pregnant patient faces delays or denials of timely emergency care. This is a declaratory statement of policy, not a new law, aimed at reinforcing existing federal standards and clarifying Hawaii's commitment to reproductive healthcare access during medical emergencies.
Specifies that no person is subject to liability for providing clinical preventive services in accordance with Department of Health recommendations. Requires health insurers, mutual benefit societies, health maintenance organizations, and plans established by the Hawaii Employer-Union Health Benefits Trust to provide coverage for clinical preventive services. Authorizes the Department of Health to make recommendations relating to clinical preventive services and issue standing orders for medications and immunizations. Clarifies that, for coverage for child health supervision services, the prevailing medical standards include recommendations by the Department of Health. Specifies that coverage for clinical preventive services shall not be denied on the basis of medical necessity or subject to prior authorization. Specifies that a registered pharmacist may order a vaccine in accordance with the recommendations from the Department of Health. Exempts this measure from an Auditor impact assessment report. Effective 1/30/2050. (SD1)
This Senate Concurrent Resolution urges Hawaii's Department of Health to coordinate the stockpiling of a three-year supply of mifepristone, a medication commonly used in medical abortions. The resolution is based on concerns about potential disruptions to the medication's supply chain and aims to ensure continued access to abortion care within the state. It directs the Department of Health to determine the appropriate quantities for this stockpile and requires sending a copy of the resolution to the state's health director. The measure does not mandate specific actions but serves as a formal recommendation to the health department regarding medication availability.
Adopts the Uniform Health Care Decisions Act (2023), as modified, to replace existing chapters related to advance health care directives and advance mental health care directives. Requires the Attorney General to convene a working group. Requires a report to the Legislature. Effective 1/30/2050. Implementation effective 7/1/20209. (SD2)
Expands the protections established under Act 2, SLH 2023, to include gender-affirming health care services. Clarifies jurisdiction under the Uniform Child-Custody Jurisdiction and Enforcement Act for cases involving children who obtain gender-affirming health care services. Effective 12/31/2050. (SD1)